Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 425

2.

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J.

JAMA. 1996 Dec 18;276(23):1886-92. Erratum in: JAMA 1997 May 7;277(17):1356.

PMID:
8968014
3.

Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.

Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, Lacy CR, Perry HM Jr, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Applegate WB.

JAMA. 1997 Jul 16;278(3):212-6.

PMID:
9218667
4.

Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).

Perry HM Jr, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, Kuller L, Pressel S, Stamler J, Probstfield JL.

JAMA. 2000 Jul 26;284(4):465-71.

PMID:
10904510
5.

The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.

Probstfield JL, Applegate WB, Borhani NO, Curb JD, Cutler JA, Davis BR, Furberg CD, Hawkins CM, Lakatos E, Page LB, et al.

Clin Exp Hypertens A. 1989;11(5-6):973-89.

PMID:
2676266
6.

Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.

Petrovitch H, Vogt TM, Berge KG.

Geriatrics. 1992 Mar;47(3):30-2, 35-8. Review.

PMID:
1544585
7.

Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.

Staessen JA, Fagard R, Thijs L, Celis H, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Fletcher AE, Babarskiene MR, Forette F, Kocemba J, Laks T, Leonetti G, Nachev C, Petrie JC, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Zanchetti A.

Arch Intern Med. 1998 Aug 10-24;158(15):1681-91.

PMID:
9701103
8.

Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).

Kostis JB, Berge KG, Davis BR, Hawkins CM, Probstfield J.

Am J Hypertens. 1995 Dec;8(12 Pt 1):1147-53.

PMID:
8998247
9.

Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Davis BR, Vogt T, Frost PH, Burlando A, Cohen J, Wilson A, Brass LM, Frishman W, Price T, Stamler J.

Stroke. 1998 Jul;29(7):1333-40.

10.

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.

Kjeldsen SE, Dahlöf B, Devereux RB, Julius S, Aurup P, Edelman J, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn S, Wedel H; LIFE (Losartan Intervention for Endpoint Reduction) Study Group.

JAMA. 2002 Sep 25;288(12):1491-8.

PMID:
12243636
11.

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

JAMA. 2002 Dec 18;288(23):2981-97. Erratum in: JAMA. 2004 May 12;291(18):2196. JAMA 2003 Jan 8;289(2):178.

PMID:
12479763
12.

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.

Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J.

Arch Intern Med. 1998 Apr 13;158(7):741-51.

PMID:
9554680
14.

Association between chlorthalidone treatment of systolic hypertension and long-term survival.

Kostis JB, Cabrera J, Cheng JQ, Cosgrove NM, Deng Y, Pressel SL, Davis BR.

JAMA. 2011 Dec 21;306(23):2588-93. doi: 10.1001/jama.2011.1821.

PMID:
22187278
15.

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A.

Lancet. 1997 Sep 13;350(9080):757-64.

PMID:
9297994
18.

Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).

Franse LV, Pahor M, Di Bari M, Shorr RI, Wan JY, Somes GW, Applegate WB.

J Hypertens. 2000 Aug;18(8):1149-54.

PMID:
10954008
19.

Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.

Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, Greenlick MR, Hadley E, Moye L, Perry HM Jr, et al.

Arch Intern Med. 1994 Oct 10;154(19):2154-60.

PMID:
7944835
20.

Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program.

Patel AB, Kostis JB, Wilson AC, Shea ML, Pressel SL, Davis BR.

Stroke. 2008 Apr;39(4):1084-9. doi: 10.1161/STROKEAHA.107.500777. Epub 2008 Feb 28.

Supplemental Content

Support Center